Immunis.AI
Healthcare Software · Michigan, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1310 N Stephenson Hwy Ste 101, Royal Oak...Phone Number
(248) 918-0468Website
www.immunis.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Immunis.AI
ImmunisAI offers innovative AI solutions in the field of immunology and healthcare. Their products and services are tailored to provide cutting-edge technologies that help clients optimize their immunology research and treatments. With a focus on integrating artificial intelligence into healthcare, ImmunisAI caters to researchers, healthcare professionals, and organizations looking to leverage advanced technology for better patient outcomes.Explore more
Immunis.AI Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunis.AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Immunis.AI has new funding data
Click to see if Immunis.AI had a recent Job posting/layoffs
Check out if Immunis.AI is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Immunis.AI has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Immunis.AI launches new products
Immunis.AI, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Immunis.AI recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Immunis.AI
Recommended Actions
Reach out to Masked Content who joined Immunis.AI as Masked Content
Find 2 more new buyers
Compare Similar Companies to Immunis.AI
Compare insights from companies similar to Immunis.AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Immunis.AI is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Immunis.AI is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Immunis.AI.
Immunis.AI financials insights
Gather financial insights about Immunis.AI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Unspecified
$40M
Immunis.AI Tech Stack
A closer look at the technologies used by Immunis.AI
See more technologies
Immunis.AI News & Media
Immunis.AI Reports Results of a Prospective Study of its RNAseq-Based Liquid-Biopsy in Early-Stage Prostate Cancer
ROYAL OAK, Mich.--(BUSINESS WIRE)--Immunis.AI, Inc., an immunogenomics platform company developing noninvasive blood-based tests to optimize patient care, today announced the publication of pivotal results from its clinical trial, Evaluation of an RNAseq-based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer, in the journal Cells. Study findings validate the potential of the company’s proprietary Intelligentia platform to detect early-stage cancer and to stratify risk in menImmunis.AI Chosen by Amazon Web Services to Showcase its Cloud-Based Genomic Pipeline for Machine Learning
ROYAL OAK, Mich.--(BUSINESS WIRE)--Immunis.AI, Inc., an immunogenomics platform company developing noninvasive blood-based tests to optimize patient care, today announced that Amazon Web Services (AWS) will showcase the company’s cloud-based genomic pipeline for machine learning. In collaboration with Mission Cloud Services, the platform will be highlighted in a virtual event, Behind the Innovation, hosted by AWS, today. Immunis.AI engaged Mission, a partner with deep life science expertise, toImmunis.AI Achieves Development Milestones and Additional Financing
ROYAL OAK, Mich.--(BUSINESS WIRE)--Immunis.AI, Inc., an immunogenomics platform company developing noninvasive blood-based tests to optimize patient care, today announced the close of additional financing that brings its total raised to $40 million to date for the ongoing development of its proprietary Intelligentia immunogenomic platform. The additional funding comes on the heels of successful completion of key development milestones, including three pivotal studies of the Intelligentia platfoImmunis.AI Presents Discovery of Cancer-Related Signals in Circulating Monocytes
ROYAL OAK, Mich.--(BUSINESS WIRE)--Immunis.AI, Inc., an immunogenomics platform company developing noninvasive blood-based tests to optimize patient care, today announced it has presented key findings in a poster presentation at the International Conference on Clinical and Single Cell Analysis held in Lisbon, Portugal. The presentation reported on the discovery of signals of prostate (cancer) origin within circulating monocytes and supports the company’s proprietary immunogenomic approach to ea
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunis.AI
Sign Up For FreeTo access detailed company insights
ImmunisAI offers innovative AI solutions in the field of immunology and healthcare. Their products and services are tailored to provide cutting-edge technologies that help clients optimize their immunology research and treatments. With a focus on integrating artificial intelligence into healthcare, ImmunisAI caters to researchers, healthcare profes... Read More
